Additive Orthopaedics LLC reported on Monday the receipt of the US FDA 510(k) clearance for its Patient Specific 3D Printed Locking Lattice Plates indicated for alignment, stabilisation and fusion of fractures, osteotomies and arthrodesis of small foot and ankle bones.
According to the company, there will always be a need for traditional off-the-shelf orthopaedic devices, but in cases of implant revisions, limb salvage, and trauma, using printing to manufacture a patient specific device can potentially lead to a better outcome.
In addition, the patient specific implants will be the cornerstone of Game Plan, an integrated surgical planning system launching later this year.
The early stage orthopaedic company is focused on the integration of advanced manufacturing and biologics for the benefit of a better patient outcome.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project